|
2319
|
L 002
|
Inhibitor of p300 HAT (KAT3B) and p53 acetylation |
€80.00 |
|
1127
|
L 454560
|
PDE4 inhibitor |
Inquire |
|
1196
|
L 838417
|
GABAA-α1 antagonist |
€90.00 |
|
3390
|
L-655,708
|
Selective inverse agonist of GABAA-α5 |
€120.00 |
|
1317
|
L-Ascorbyl dodecanoate
|
Vitamin C ester; Antioxidant |
€130.00 |
|
1316
|
L-Ascorbyl octanoate
|
Vitamin C ester; Antioxidant |
€130.00 |
|
3666
|
L-DOPA
|
Dopamine precursor |
€50.00 |
|
2427
|
L-TBOA ammonia salt
|
Very potent blocker of EAAT1–3 |
€135.00 |
|
3185
|
L651582
|
Ca2+ channel blocker |
€120.00 |
|
2549
|
L67
|
Cytotoxic inhibitor of DNA ligase I and III |
€90.00 |
|
3683
|
L6H21
|
Specific MD-2 inhibitor |
€120.00 |
|
1444
|
Lacosamide
|
Na+ channel blocker; anti-convulsant |
€70.00 |
|
2797
|
Lalistat 2
|
Selective inhibitor of lysosomal acid lipase (LAL) |
€99.00 |
|
3304
|
Lamivudine
|
Potent NRT inhibitor |
€60.00 |
|
1353
|
Lamotrigine
|
Glutamate antagonist; Na+ channel blocker |
€60.00 |
|
3244
|
Lansoprazole
|
Proton pump inhibitor (PPI) |
€40.00 |
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1970
|
Laquinimod
|
Selective autoimmune suppressant; Immunomodulator |
€70.00 |
|
1794
|
LB 42708
|
Inhibitor of farnesyltransferase (FTase) |
€95.00 |
|
2820
|
LB-100
|
Specific, competitive inhibitor of PP2A |
€110.00 |
|
1548
|
LBH 589
|
HDAC1 Inhibitor |
€90.00 |
|
2176
|
LCS-1
|
Inhibits SOD1 enzymatic activity. Lead compound for lung cancer therapeutics |
€85.00 |
|
3791
|
LCS3
|
Reversible and uncompetitive inhibitor of GSR and TXNRD1 |
Recently added
|
€90.00 |
|
3029
|
LDC000067
|
Potent, highly specific, ATP-competitive CDK9 inhibitor |
€110.00 |
|
3482
|
LDC7559
|
PFKL activator |
€155.00 |
|
2224
|
LDK 378
|
Potent, bioavailable, and selective anaplastic lymphoma kinase (ALK) inhibitor |
€95.00 |
|
1509
|
LDN 193189 hydrochloride
|
Highly potent small molecule inhibitor of BMP type I receptors ALK2, ALK3, and ALK6 |
€65.00 |
|
2260
|
LDN 212320
|
Activator of EAAT2 translation; neuroprotectant |
€90.00 |
|
3552
|
LDN 212854
|
Potent ALK2-biased BMP type I receptor kinase inhibitor |
€110.00 |
|
2201
|
LDN 212854 trihydrochloride
|
Potent ALK2-biased BMP type I receptor kinase inhibitor |
€110.00 |